Could the IgA isotype provide additional information in systemic sclerosis patients? A retrospective study entailing IgA isotyping in a Mediterranean systemic sclerosis cohort.

Autor: Pérez-Isidro A; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic, Barcelona, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Lledó-Ibáñez GM; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona; Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona; and Reference Centre for Systemic Autoimmune Diseases (CSUR) of the Spanish Health System, Barcelona, Spain., de Moner N; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic, Barcelona, Spain., Torradeflot M; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic, Barcelona, Spain., Martínez MJ; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic, Barcelona, Spain., Espinosa G; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona; Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona; and Reference Centre for Systemic Autoimmune Diseases (CSUR) of the Spanish Health System, Barcelona, Spain., Tena Campos M; Thermo Fisher Scientific, Cornellà de Llobregat, Spain., Grundhuber M; Thermo Fisher Scientific, Freiburg, Germany., Viñas O; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic, Barcelona, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. ovinyas@clinic.cat., Ruiz-Ortiz E; Department of Immunology, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic, Barcelona, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. esruiz@clinic.cat.

Publikováno v: Clinical and experimental rheumatology [Clin Exp Rheumatol] 2024 Aug; Vol. 42 (8), pp. 1556-1563. Date of Electronic Publication: 2023 Sep 29.

Low Levels Matter: Clinical Relevance of Low Pru p 3 sIgE in Patients With Peach Allergy.

Autor: Balsells-Vives S; Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., San Bartolomé C; Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Department of Immunology, Centre de Diagnòstic Biomedic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain., Casas-Saucedo R; Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Allergy Section, Department of Pneumology, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain.; Spanish Research Network on Allergy (ARADyAL, Red Nacional de Alergia-Asma, Reacciones Adversas y Alérgicas-), Instituto de Salud Carlos III, Madrid, Spain., Ruano-Zaragoza M; Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Allergy Section, Department of Pneumology, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain.; Spanish Research Network on Allergy (ARADyAL, Red Nacional de Alergia-Asma, Reacciones Adversas y Alérgicas-), Instituto de Salud Carlos III, Madrid, Spain., Rius J; Department of Immunology, Centre de Diagnòstic Biomedic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain., Torradeflot M; Department of Immunology, Centre de Diagnòstic Biomedic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain., Bartra J; Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Allergy Section, Department of Pneumology, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain.; Spanish Research Network on Allergy (ARADyAL, Red Nacional de Alergia-Asma, Reacciones Adversas y Alérgicas-), Instituto de Salud Carlos III, Madrid, Spain., Munoz-Cano R; Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Allergy Section, Department of Pneumology, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain.; Spanish Research Network on Allergy (ARADyAL, Red Nacional de Alergia-Asma, Reacciones Adversas y Alérgicas-), Instituto de Salud Carlos III, Madrid, Spain., Pascal M; Clinical and Experimental Respiratory Immunoallergy (IRCE), Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.; Department of Immunology, Centre de Diagnòstic Biomedic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Spanish Research Network on Allergy (ARADyAL, Red Nacional de Alergia-Asma, Reacciones Adversas y Alérgicas-), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Frontiers in allergy [Front Allergy] 2022 Apr 05; Vol. 3, pp. 868267. Date of Electronic Publication: 2022 Apr 05 (Print Publication: 2022).

Alternative to In Vivo Tests During the COVID-19 Pandemic: Multiple Allergen Simultaneous Tests as a Useful First Screening.

Autor: Bartolome CS, Farre V, Rius J, Torradeflot M, Espanol-Rego M, Pascal M

Publikováno v: Clinical laboratory [Clin Lab] 2021 Dec 01; Vol. 67 (12).

Performance of basophil activation test and specific IgG4 as diagnostic tools in nonspecific lipid transfer protein allergy: Antwerp-Barcelona comparison.

Autor: Decuyper II; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.; Pediatric Department, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Pascal M; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.; Spanish Network for Allergy - RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain., Van Gasse AL; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.; Pediatric Department, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Mertens C; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Díaz-Perales A; Spanish Network for Allergy - RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain.; Plant Biotechnology Institute (UPM-INIA), Madrid, Spain., Araujo G; Allergy Section, Pneumology Department, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain., Torradeflot M; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Rius J; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Balsells S; Immunology Department, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain., Muñoz-Cano RM; Spanish Network for Allergy - RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain.; Allergy Section, Pneumology Department, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain., Bartra J; Spanish Network for Allergy - RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL), Madrid, Spain.; Allergy Section, Pneumology Department, Institut Clínic Respiratori (ICR), Hospital Clínic de Barcelona, Barcelona, Spain., Li L; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Sabato V; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Hagendorens MM; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.; Pediatric Department, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Bridts CH; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., De Clerck LS; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Ebo DG; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium., Faber MA; Department of Immunology-Allergology-Rheumatology, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.

Publikováno v: Allergy [Allergy] 2020 Mar; Vol. 75 (3), pp. 616-624. Date of Electronic Publication: 2019 Oct 07.

Existence of a soluble form of CD50 (intercellular adhesion molecule-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients

Autor: Pino-Otín MR, Viñas O, Ma, La Fuente, Manel Juan, Font J, Torradeflot M, Pallarés L, Lozano F, Alberola-Ila J, Martorell J

Publikováno v: Europe PubMed Central
ResearcherID

CD50 (ICAM-3) is a leukocyte differentiation Ag expressed almost exclusively on hemopoietic cells, with a key role in the first steps of immune response. To develop a specific sandwich ELISA to detect a soluble CD50 form (sCD50), two different mAbs (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e338725814cc1c01da526d925eaa3f6
https://pubmed.ncbi.nlm.nih.gov/7876564